Chemical Business Newsbase articles from March 2002, page 10

Chemical Business Newsbase archives from March 2002

Gazeta Mercantil: Private companies struggle to bring gas from Bolivia.
March 14, 2002... Threatened by the falling price of fuel oil, the Brazilian natural gas industry wishes to import natural gas directly from Bolivia in order to cut costs. In order to do this, however, private companies need access to the Brazil-Bolivia gas...

The Independent: Anglo American warns of difficult year ahead after profits plunge 11%.
March 14, 2002... Anglo American, the mining group, warned of a difficult year ahead, after posting an 11% drop in underlying pre-tax profits for 2001. The global economic slowdown has seen metal prices sag, forcing pre-tax profits down from $3.8 bn (#2.7 bn)...

The Independent: Market Report: Biocompatibles.
March 14, 2002... On 13 Mar 2002, there were rumours that Biocompatibles, up 8.5p to 97.5p, was in takeover talks with Abbott Laboratories. A link-up between the two has long been rumoured with some suggesting that the US group may be willing to pay as much...

The Independent: Market Report: Amersham.
March 14, 2002... Amersham made up Monday's (11 Mar 2002) losses adding 30p to 735p as brokers for the company placed 50 M new shares to fund the group's acquisition of Pharmacia Corp ahead of schedule. (Full text).

Business Line: Gulf Oil, IDL merger at 2:1 swap ratio.
March 13, 2002... The boards of Gulf Oil Ltd and IDL Industries Ltd have approved a swap rate of two shares of Gulf Oil for every equity share of IDL Industries for the merger of the two companies.

Business Line: Post-deregulation crude import: Doubts over SCI's nodal status.
March 13, 2002... It is not certain if the State-owned Shipping Corp of India (SCI) would continue as the nodal agency for transportation of crude oil imported by oil companies in India, in the deregulated regime starting 1 Apr 2002. For the Government of...

Business Line: Dr Reddy's to buy two UK-based companies.
March 13, 2002... Hyderabad-based pharma major Dr Reddy's Laboratories Ltd (Dr Reddy's) is making its first overseas acquisition by taking over UK-based BMS Laboratories Ltd and Meridian Healthcare (UK) Ltd, a 100% subsidiary of BMS Laboratories, for #9.05 M....

Business Line: Tata Refractories to go in for revamp, focus on exports.
March 13, 2002... Tata Refractories Ltd proposes to undertake a major restructuring plan that includes: reducing the plant and equipment age by 10 to 15 years over a two years timeframe from 2002; manpower reengineering; and a qualitative shift towards...

Business Line: Bayer to apply for trials on Ranbaxy drug.
March 13, 2002... Germany-based Bayer AG is likely to file an application to start clinical trials for its 1000 mg once-a-day dosage form of the antibiotic ciprofloxacin in the US by quarter ending Dec 2002. New-Delhi based Ranbaxy licensed the once-a-day...

Business Line: Akzo Nobel stake in Infar crosses 97%.
March 13, 2002... The EUR 938 M Dutch multinational Akzo Nobel has acquired over 97% stake in Infar India Ltd in its bid to make it a 100% subsidiary. Akzo Nobel first acquired 25.53% stake from the Indian partner, the Mehtas, and then acquired 24.04% through...

Business Line: Continental ties up with Metro group for rubber sports wheels.
March 13, 2002... Global tyre major, Germany-based Continental AG has tied up with the Rup 3 bn Metro group to set up a hi-tech rubber sports wheel plant in India. The project will utilise the latest technology developed by Continental AG after four years of...

Business Line: TM International to begin Haldia operations soon.
March 13, 2002... TM International Logistics Ltd (TM International), a subsidiary of Tata Steel and a joint venture of Tata Steel and Germany-based Martrade & Holding GmbH, will handle its first shipment of 30,000 tonnes of limestone from Dubai to Haldia in...

Business Line: BPCL tenders to buy May crude.
March 13, 2002... Bharat Petroleum Corp Ltd (BPCL) has issued three buy tenders seeking a total of 1.5 M bbls of crude oil for May 2002,. The crude grades eligible include Gulf of Suez Mix, Dubai, Upper Zakum and Masila among others.

Gazeta Mercantil: Petrobras hikes gasoline prices 9.39%.
March 13, 2002... Brazil's state oil company, Petrobras, is to increase by 9.39% the price of gasoline sold at its refineries from 16 Mar 2002. Pump prices are expected to go up by 7.5%, which will increase inflation by 35 basis points.

The Independent: Amersham to spend #700 M on Biosciences buyout.
March 13, 2002... The healthcare company Amersham is to spend #700 M to take full control of its life sciences joint venture. Amersham has launched a #350 M share placing to help pay for the buyout of Pharmacia's 45% stake in Amersham Biosciences, which makes...

The Independent: Celltech prospects look sickly.
March 13, 2002... Celltech is under pressure on two fronts. It has poured money into research and development (more, in fact, than analysts had been forecasting) but there are growing doubts about the returns that can be expected from the investment....

Federal Register: Adjustment of import limits for certain cotton, wool and man-made fiber textile products produced or manufactured in Guatemala.
March 13, 2002... On 8 Mar 2002 the US Committee for the Implementation of Textile Agreements (CITA) issued a directive to the Commissioner of Customs adjusting import limits for certain cotton, wool and man-made fiber textile products produced or manufactured...

Federal Register: Dimethoate products cancellation order and label amendment.
March 13, 2002... This notice announces the US Environmental Protection Agency's cancellation order for the product and use cancellations as requested by companies (hereafter collectively referred to as the "EUP Registrants'') that hold the registrations of...

Ernaehrungsdienst: Kemira divests fertilizer activities. Still seeking investor for agrochemicals division.
March 13, 2002... Finnish Kemira Group plans to split off the fertilizer division (Kemira Agro) into an independent company. Kemira Agro consists of the field fertilizer business Kemira Agro Nitrogen (KAN) and the speciality fertilizers business Kemira Agro...

Chemical Week: Krupp Uhde awarded fertilizer contract in Turkmenistan.
March 13, 2002... A new fertilizer complex is to be built by Krupp Uhde for Gap Insaat (a subsidiary of Calik Holding) at Tedjen in Turkmenistan. The complex will have a capacity to produce 600 tonnes/day ammonia and 1050 tonnes/day urea. Krupp Uhde's...

Chemical Week: Asahi Kasei hikes MMA capacity in Japan.
March 13, 2002... Yen 2 bn is to be invested by Asahi Kasei to increased methyl methacrylate (MMA) capacity at Kawasaki, Japan by 30,000 tonnes/y from its current total of 70,000 tonnes/y. Completion is expected in Nov 2002. Proprietary technology will be used...

Chemical Week: ABB Lummus Global confirms Oman contract.
March 13, 2002... Novolen polypropylene technology developed by a joint venture between ABB Lummus Global and Equistar Chemicals is to be used in a 340,000 tonnes/y PP plant to be built by ABB Lummus Global at Sohar, Oman. The complex will be owned by a joint...

Chemical Week: Qapco plans ethylene capacity hike at Mesaieed.
March 13, 2002... Ethylene capacity is to be increased by Qatar Petrochemical Co at Mesaieed in Qatar from 525,000 tonnes/y to 720,000 tonnes/y. Likely bidders for the contract could include ABB Lummus Global, Linde and Technip-Coflexip. Capacity for low...

Chemical Week: Slovak firm raises caprolactam capacity.
March 13, 2002... EUR 14 M has been received by Aquachemie (owned by Bonazzi Group) from the European Bank for Reconstruction and Development to modernize and expand caprolactam capacity from 25,000 tonnes/y to 37,000 tonnes/y at Zilina in the Slovak Republic....

Chemical Week: Innovative growth: just one word: textronics.
March 13, 2002... The development of new materials including textronics, a combination of textiles and electronics, is investigated. Dow Chemicals predicts that 15%/y of its 10%/y revenue growth will come from products introduced within the last five years. In...

Chemical Week: Designer polymers, on the cheap.
March 13, 2002... Warwick Effect Polymers is a new company created by a research group at the University of Warwick, UK to commercialize a patented process for growing cheap designer polymers. The process uses a copper-based catalyst and an undisclosed organic...

Chemical Week: Transition metal hydrides promise novel properties.
March 13, 2002... A new class of electronic and magnetic materials is being developed by scientists at the University of Liverpool, the University of Oxford and at the Rutherford Appleton Laboratory in the UK by inserting hydride ions into the structural...

Chemical Week: Synetix-Avecia chiral development deal.
March 13, 2002... An exclusive agreement has been signed between Synetix Chiral Technologies (part of ICI) and Avecia to develop and immobilize Avecia's patented catalytic asymmetric transfer hydrogenation and catalytic asymmetric cyanohydrin catalyst...

Chemical Week: Indian drug firm targets the US.
March 13, 2002... A drug development and marketing agreement has been signed by Wockhardt Ltd (Bombay) with Ranbaxy Laboratories, the largest pharmaceutical manufacturer in India. The anti-ulcerant ranitidine and the cardiac drug enalapril will be covered by...

Chemical Week: Paradigm reports a loss: axes its CEO.
March 13, 2002... During 2001 a net loss of $16 M was recorded by Paradigm Genetics, the biotech company that specializes in agricultural genomics, on sales that improved 137% to $24.5 M. A net loss of $29.7 M was reported during 2000. The company is based in...

Chemical Week: Mitsui bisphenol starts Singapore unit.
March 13, 2002... A second 70,000 tonnes/y bisphenol A plant has been started up by Mitsui Bisphenol Singapore at Jurong Island in Singapore. A third 70,000 tonnes/y plant is due to be brought on stream at the same site in Sep 2002 increasing Mitsui's BPA...

Chemical Week: EPA plans catch-all toxics rule for unregulated processes.
March 13, 2002... A new catch-all regulation has been proposed by the EPA to mandate air toxic emissions reductions for 24 organic chemical formulation and manufacturing processes. Emission reduction requirements will be set by mandating maximum achievable...

Chemical Week: Agent orange study retracted.
March 13, 2002... The 2001 study that links exposure to the defoliant Agent Orange during the Vietnam War to the development of acute myelogenous leukaemia in the children of veterans has been retracted by the Institute of Medicine due to insufficient evidence...

Chemical Week: Fourth quarter ends with a thud. [2 tables].
March 13, 2002... A table lists sales, after-tax margins and earnings per share for a range of chemical producers for 4Q 2001 compared to 4Q 2000 listed by sector (basic chemicals; diversified chemicals; speciality chemicals; industrial gases; agrochemicals;...

Chemical Week: Davison Catalysts offers value-added catalysts and services for refiners.
March 13, 2002... Davison Catalysts, the refining and chemical catalysts division of WR Grace & Co is profiled. Its business is based on silica and alumina. The focus is on clean fuels solutions, gasoline sulfur reduction, other services for refiners and...

Chemical Week: CRI catalyst company: got problems? We have the answers.
March 13, 2002... The CRI Catalyst Company, part of Royal Dutch Shell Group, is profiled. Details include an overview of the company with the focus on ethylene oxide catalysts, styrene catalysts, hydrogenation catalysts and environmental catalysts and systems.

Chemical Week: Avantium Technologies: faster innovation and speed to market using high throughput technology.
March 13, 2002... Avantium Technologies that provides an R&D service to the chemical and pharmaceutical industries is profiled. The company's success is based on its catalyst library, micro reactor arrays, high speed analysis and information and simulation....

The Star (Malaysia): Mega First associate to buy Broken Hill Mine.
March 13, 2002... Australia-based Perilya Ltd, a 19.56%-owned associated company of Mega First Corp Bhd, has entered an agreement with Pasminco Ltd to acquire Broken Hill Mine, a lead-zinc-silver mine located in western New South Wales. According to the...

Dagens Industri: Boliden and NAN collaborate in Skelleftea.
March 13, 2002... Boliden and North Atlantic Natural Resources (NAN) have signed an agreement which will give each the right to carry out prospecting in areas of Skelleftea, Sweden, in which the other holds rights. The agreement will give Boliden the...

Press Release: Collateral Therapeutics acquires rights to the EPAS1 gene for use in gene therapy applications.
March 13, 2002... Collateral Therapeutics Inc has entered into an option agreement to licence exclusive worldwide gene therapy rights from the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) for the Endothelial PAS domain protein 1...

Press Release: Array BioPharma announces drug discovery collaboration with Japan Tobacco.
March 13, 2002... Array BioPharma Inc has entered into a drug discovery collaboration agreement with the pharmaceutical division of Japan Tobacco Inc to create small molecule therapeutics against a proprietary Japan Tobacco target. Japan Tobacco will fund drug...

Press Release: SkyePharma to acquire 100% of RTP Pharma Inc; signs agreement to fund new product development - HFA-Formoterol and RTP's Propofol.
March 13, 2002... SkyePharma PLC announced the acquisition of 59.8% of the outstanding voting shares of RTP Pharma Inc in return for the issue of SkyePharma Ordinary Shares to the value of $20.6 M, thereby securing ownership of the Canadian company. RTP Pharma...

Press Release: Zadaxin in combination therapy has significantly superior sustained response rates compared to interferon monotherapy for hepatitis B.
March 13, 2002... SciClone Pharmaceuticals announced that data presented at the World Congress of Gastroenterology in Bangkok, Thailand, indicate that after an additional 12-month follow-up period for difficult to treat chronic hepatitis B patients in Turkey,...

Press Release: Haemacure to take over of Hemaseel HMN project with the assistance of ZLB Bioplasma.
March 13, 2002... Haemacure Corp announced a restructuring of its arrangements with ZLB Bioplasma AG, a wholly owned subsidiary of CSL Ltd of Melbourne, Australia, whereby Haemacure will take control of the manufacturing, clinical studies and registration...

Press Release: Got Botox?; Dr Harvey 'Chip' Cole offers non-surgical wrinkle solution.
March 13, 2002... With FDA approval for cosmetic applications of Botox Wrinkle Treatment expected, consumer demand for the already popular procedure is expected to increase 100%. To handle the increased volume, Botox manufacturer Allergan Pharmaceutical, named...

Press Release: Aventis Pharma and Coley Pharmaceutical Group expand partnership.
March 13, 2002... Coley Pharmaceutical Group Inc has expanded its existing collaboration with Aventis Pharma to include a drug discovery programme to screen and evaluate second-generation immunomodulatory CpG product candidates (CpG oligos) for the treatment...

Press Release: Trisenox granted marketing authorization in Europe from the European Commission.
March 13, 2002... Cell Therapeutics (UK) Ltd, a wholly owned subsidiary of Cell Therapeutics Inc, announced that the European Commission has granted the Marketing Authorization for Trisenox (arsenic trioxide), indicated for the induction of remission and...

Press Release: Biotherapies Inc finalizes sale of diagnostic unit.
March 13, 2002... Biotherapies Inc of Ann Arbor, MI, has completed the sale of the diagnostic unit that the company started as a joint venture with Genesis Bioventures (GBI). Biotherapies started the joint venture, Biomedical Diagnostics, with GBI in 1998 to...

Press Release: NeoTherapeutics raises $5.15 M in a private placement led by Royal Bank Investment Management.
March 13, 2002... NeoTherapeutics Inc raised $5.15 M through the sale of common stock to a group of institutional investors led by Royal Bank Investment Management. In addition, the company issued warrants to purchase common stock at a price of $2.75/share....

Press Release: Federal Court rules in Augmentin Patent challenge; GSK to appeal ruling on patents expiring in 2017 and 2018.
March 13, 2002... GlaxoSmithKline (GSK) announced that a federal judge in the US District Court for the Eastern District of Virginia has ruled on a summary judgment motion filed by Teva Pharmaceuticals (Teva), relating to the validity of three of GSK's patents...

Press Release: Researchers at The Children's Hospital of Philadelphia find eye drops work as well as patches for lazy eye, are better accepted by children.
March 13, 2002... Researchers at The Children's Hospital of Philadelphia have concluded that the use of an eye patch or atropine eye drops are equally effective treatments for amblyopia, also referred to as lazy eye. The results are published in the Mar 2002...

Press Release: US Army Space & Missile Defense Command to procure reagents from Igen for detection of biological agents.
March 13, 2002... Igen International Inc (Igen) has signed an agreement to sell products to the US Army Space and Missile Defense Command based on Igen's Origen technology for the detection of specific biological agents important to the US Department of...

Press Release: Spartech targets future growth through new alloy plastics, product transformations & strategic expansions.
March 13, 2002... Shareholders attending the Annual Meeting of Spartech Corp were told that several infrastructure changes made since Oct 2001 have allowed the company to improve its operations and reinforce its financial position to support future growth. Two...

Press Release: Digene reaches new milestone in lab customers for its Hybrid Capture 2 HPV DNA Test.
March 13, 2002... Digene Corp announced that over 200 laboratories in the US now provide testing for human papillomavirus (HPV), using the Digene Hybrid Capture 2 HPV DNA Test, in cervical cancer screening programmes. In addition to major labs in the US,...

Neue Zuercher Zeitung: Bayer sells household insecticides division.
March 13, 2002... German Bayer Group plans to sell its household insecticides business (Baygon and Autan brands) by the end of 2002. Bayer aims to concentrate the activities of the healthcare division on pharmaceuticals, animal healthcare products and...

Neue Zuercher Zeitung: Merck expands generic drugs business.
March 13, 2002... German pharmaceuticals company Merck acquired the Japanese generic drugs manufacturer Mohan. The acquisition will strengthen Merck's position in the Japanese pharmaceuticals market, and will double turnover by Merck's Japanese generic drugs...

Nachrichten fuer Aussenhandel: Merck completes acquisition in Japan.
March 13, 2002... German Merck KGaA in Darmstadt completed the acquisition of Japanese generic drugs manufacturer Mohan Medicine Research Institute in Tokyo. Mohan will be integrated in the existing generic drugs business of Merck Hoei. The measure will double...

Press Release: Gilead initiates Early Access Program for adefovir dipivoxil, investigational treatment for chronic hepatitis B infection.
March 12, 2002... Gilead Sciences Inc (Gilead) announced the initiation of an Early Access Program (EAP) to provide its investigational agent adefovir dipivoxil 10 mg to people with chronic hepatitis B virus (HBV) infection resistant to the currently available...

Nachrichten fuer Aussenhandel: Stada increases stake in Ciclum Farma.
March 12, 2002... German company Stada Arzneimittel AG in Bad Vilbel increased its shareholding in Spanish distributor Ciclum Farma SA in Madrid from 50% to 74%. The transaction was backdated to 1 Jan 2002. The remaining 26% of shares have been acquired by...

Nachrichten fuer Aussenhandel: Vehicles in Japan. Continental expands partnership with Bridgestone.
March 12, 2002... German tyre manufacturer Continental AG in Hanover and Japanese tyre manufacturer Bridgestone Corp in Tokyo will expand their existing partnership for emergency tyre systems. The partners aims to set global standards for emergency tyre...

Nachrichten fuer Aussenhandel: Technology in Singapore. Search for investors in biotechnology.
March 12, 2002... The government in Singapore aims to promote the domestic biotechnology and genetic engineering industry, and will establish an office on 1 April 2002 in London to attract interested companies. Singapore's investments in the biomedical...

Nachrichten fuer Aussenhandel: Pharmaceutials market in Croatia. Pliva achieved surge in turnover and profit.
March 12, 2002... Pliva AG in Croatia is the largest pharmaceuticals manufacturer in Central, Eastern and South Eastern Europe. The company achieved a net profit of HRK 1.1 bn in 2001 (HRK 1.14 bn in 2000). Turnover increased by 6.2%to HRK 5.27 bn in 2001....

Chemical Week: Investigations initiated into imports of STPP from China and Taiwan. [2 tables].
March 12, 2002... The Designated Authority in the Ministry of Commerce and Industry, in response to the petition filed by Albright & Wilson Chemicals India Ltd and Hind Lever Chemicals of Hindustan Lever group, has started investigations into dumping of sodium...

Chemical Week: Hikal sets up stand-alone 'Thermal Oxidiser' at Dombivili.
March 12, 2002... Fine chemicals major Hikal Ltd has forayed into industrial waste management by setting set up a stand alone waste disposal incinerator facility at Dombivili near Mumbai. The thermal oxidizer, manufactured with in-house technology, has a...

Chemical Week: Provisional dumping duty likely on HF from China. [1 table].
March 12, 2002... The Designated Authority in the Ministry of Commerce and Industry, based on its preliminary findings, has recommended imposition of provisional anti-dumping duty on imports of all concentrations of hydrofluoric acid (HF) expect 70% from...

Chemical Week: Stimulus package for pharma R&D on the cards.
March 12, 2002... The Central Government Cabinet is likely to announce several incentives to encourage R&D activities in the pharmaceutical industry. The incentives package, worked out after taking into consideration the recommendations of the Committee set up...

Chemical Week: Industry urges CVD exemption for imported life-saving drugs.
March 12, 2002... The importers of life-saving drugs have proposed to urge the Government of India to exempt these drugs from countervailing duty (CVD), so that the customer can ensue the reduced prices. The Government of India, which removed the 5% basic...

Chemical Week: Cipla cuts AIDS drug prices by 11%; others likely to follow.
March 12, 2002... Cipla Ltd has reduced the prices of its nine anti-HIV drugs based on lamivudine, stavudine, didanosine, saquinavir, ritonavir, indinavir, efavirenz, nelfinavir and nevirapine. The Government has exempted these nine drugs from excise duty as...

Chemical Week: SH Kelkar & Co: Tracing the growth of India's premier perfumery house.
March 12, 2002... The 80-year old, Rup 1.8 bn perfumes major SH Kelkar & Co P Ltd has relied entirely on in-house R&D activities for growth in the Rup 5 bn Indian fragrances industry. SH Kelkar & Co has, in its product basket, about 2000 perfumes, which find...

Chemical Week: Bright role for plastics industry if it addresses issue of waste management adequately.
March 12, 2002... Chennai-based Central Institute of Plastics Engineering and Technology has envisaged bright future for the Indian plastics industry, if it can handle waste management effectively. The estimated consumption of plastics in India is estimated at...

Europe Environment: Phthalates: Commission extends ban in toys.
March 12, 2002... The European Commission has decided to continue the temporary ban on phthalates in soft plastic (PVC) toys and teething articles for a further three months to 22 May. This is the ninth time the ban has been extended.

The Star (Malaysia): PPB Group optimistic with improved outlook for 2002.
March 12, 2002... PPB Group Bhd is all set to improve its financial performance during the year ending Dec 2002, as its main segments including food, plantations, property and entertainment are expected to fare better. With an expected increase in crude palm...

Dagens Industri: Pharmacia sells ownership in Amersham Biosciences.
March 12, 2002... Pharmacia is selling its 45% stake in Amersham Biosciences to Amersham for $1 bn. Amersham will thereby gain full ownership in Amersham Biosciences which produces integrated biosystems for biotechnology and drug companies. The divestment is...

Dagens Industri: Karo Bio gets American grant for prostate cancer research.
March 12, 2002... Karo Bio USA Inc will receive a grant from Armen, US, for research over a 3-year period aimed at developing drugs for the treatment of prostate cancer. Karo Bio's technology will be used to elucidate the link between androgen receptor...

Het Financieele Dagblad: Shell to sell Oman liquid natural gas to Spain.
March 12, 2002... Shell is to sell 700,000 tonne/y liquid gas from Oman on the Spanish market. These deliveries will provide around 6% of total demand in Spain. In 2000 the Spanish demand for gas rose by 12%, which was four times higher than the average...

Press Release: Serono reintroduces Crinone to the US market.
March 12, 2002... Serono SA has reintroduced Crinone 8% (progesterone gel) to the US market, effective 8 Mar 2002. This decision was based upon evaluation of product data from new batches indicating that the viscosity changes, which led to a voluntary recall...

Press Release: Ricerca LLC obtains drug development rights to new gene target from Genset SA.
March 12, 2002... Ricerca LLC has initiated its oncology drug discovery program by licensing RAP-3 cancer-associated gene from Genset SA. Ricerca intends to use RAP-3 as a drug target as well as explore the possibility of developing RAP-3 as a novel protein...

Press Release: CPMP recommends granting marketing authorization in the European Union for irbesartan in the treatment of diabetic renal disease.
March 12, 2002... Bristol-Myers Squibb Co and Sanofi-Synthelabo announced that the Committee for Proprietary Medicinal Products (CPMP) has adopted a positive opinion, recommending to grant a marketing authorization for irbesartan (Aprovel and Karvea) in the...

Press Release: LAM Pharmaceutical Corp signs marketing agreement with RxCentric Inc of New York City.
March 12, 2002... LAM Pharmaceutical Corp (LAM) has signed a marketing agreement with RxCentric Inc of New York City in connection with its anticipated launch of its breakthrough product for the management of severe skin ulcers, LAM IPMTM Wound Gel. LAM...

Press Release: Igen completes a $36.8 M equity financing.
March 12, 2002... Igen International Inc (Igen) has completed a $36.8 M private placement financing under which it sold a total of 1 M shares of its common stock to Acqua Wellington Pvt Placement Fund Ltd, and Acqua Wellington Opportunity I Ltd. The company...

Press Release: Essential Therapeutics completes acquisition of Maret Pharmaceuticals.
March 12, 2002... Essential Therapeutics Inc announced the completion of the acquisition of Maret Pharmaceuticals Inc (Maret), in a stock-for-stock exchange that closed on 11 Mar 2002. Maret is a development stage pharmaceutical company with clinical and...

Press Release: NexMed's Befar approved in Hong Kong.
March 12, 2002... NexMed Inc announced that the Department of Health has approved Befar for sale and distribution in Hong Kong. Befar is the Chinese trademark of Alprox-TD, the company's proprietary cream treatment for erectile dysfunction (ED). The product...

Press Release: Allos Therapeutics in-licenses novel chemoprotectant compound.
March 12, 2002... Allos Therapeutics Inc (Allos) and N-Gene Research Laboratories Inc (N-Gene), a privately-held company, announced that N-Gene has granted Allos licence to its intellectual property surrounding BGP-15, an orally bioavailable small molecule...

Press Release: Swiss company Debio Recherche Pharmaceutique announces agreement with inhale subsidiary Shearwater Corp to develop new hydrogel drug delivery technology.
March 12, 2002... Debio Recherche Pharmaceutique (Debio RP) announced an agreement with Shearwater Corp to develop and commercialize an innovative hydrogel technology to deliver macromolecular drugs and proteins as polyethylene-glycol (PEG)-conjugates. This...